Insilico study of Some Anticonvulsant Compounds

This book focuses on the quantitative structure-activity relationship (QSAR) and molecular docking studies of some anticonvulsant compounds. QSAR as a major factor in drug design, are mathematical equations relating chemical structure to their biological activity and it is also used to understand the structural features controlling the activities of neurotransmitters. While molecular docking is a computational technique used to predict conformation and binding affinity of intermolecular complexes based on the three-dimensional structures of an individual molecule. The modeled anticonvulsant compounds have shown that the binding affinity generated was found to be better than the commercially sold anti-epilepsy drug, vigabatrin and will be used to inhibit/deactivate the activities of gamma amino butyric acid aminotransferase (GABAAT), an enzyme that causes epilepsy.